Showing results (141-150 of 289) with videos related to
Sort By:
Pageof 29
Plos One|March 19, 2013
Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrationsJoão Ramalho-Carvalho, Malini Pires, Susana Lisboa, et al.Familial Cancer|July 11, 2006
BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer familiesAna Peixoto, Natália Salgueiro, Catarina Santos, et al.Thyroid : Official Journal of the American Thyroid Association|April 28, 2021
Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid CancerInês J Marques, Inês Gomes, Marta Pojo, et al.Plos One|November 28, 2012
Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinomaMaria J Camões, Paula Paulo, Franclim R Ribeiro, et al.BMC Medicine|May 18, 2010
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumorsMara Silva, Isabel Veiga, Franclim R Ribeiro, et al.The Breast Journal|July 24, 2014
The Brazilian founder mutation TP53 p.R337H is uncommon in Portuguese women diagnosed with breast cancerJuliana Giacomazzi, Rudinei Luis Correia, Edenir Ines Palmero, et al.Journal of Cellular and Molecular Medicine|September 12, 2014
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potentialMafalda Almeida, Vera L Costa, Natália R Costa, et al.Cancer Medicine|January 18, 2018
Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulationDiana Pinto, Carla Pinto, Joana Guerra, et al.International Journal of Cancer|September 9, 2024
Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathwaysCarolina Pires, Inês J Marques, Ana Saramago, et al.BMC Cancer|May 19, 2009
Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasiaNuno Cerveira, Joana Santos, Susana Bizarro, et al.Pageof 29